bp-1-102 and Precursor-Cell-Lymphoblastic-Leukemia-Lymphoma

bp-1-102 has been researched along with Precursor-Cell-Lymphoblastic-Leukemia-Lymphoma* in 1 studies

Other Studies

1 other study(ies) available for bp-1-102 and Precursor-Cell-Lymphoblastic-Leukemia-Lymphoma

ArticleYear
STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:11

    Topics: Aminosalicylic Acids; Animals; Antineoplastic Agents; Cell Lineage; Gene Expression Regulation, Leukemic; HMGA1a Protein; Humans; Jurkat Cells; Mice; Mice, Nude; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cells, B-Lymphoid; Signal Transduction; STAT3 Transcription Factor; Sulfonamides; Tumor Cells, Cultured; Up-Regulation; Xenograft Model Antitumor Assays

2016